Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Edelstein

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia modelP H Edelstein, M A Edelstein, F Higa, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumoniaP H Edelstein, T Shinzato, E Doyle, et al.
Clinical and Diagnostic Laboratory Immunology|May 1, 1996
Utilization of tests for Lyme disease antibody at a university hospitalI Nachamkin, D L Riddle, M Feldman, et al.
Journal of Clinical Microbiology|December 1, 1981
Comparison of liquid growth media for Legionella pneumophilaA Saito, R D Rolfe, P H Edelstein, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumoniaP H Edelstein, M A Edelstein, J Weidenfeld, et al.
Journal of Clinical Microbiology|November 1, 1987
Legionella micdadei and Legionella dumoffii monoclonal antibodies for laboratory diagnosis of Legionella infectionsE Cercenado, P H Edelstein, L H Gosting, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumoniaP H Edelstein, M A Edelstein, K H Lehr, et al.
American Journal of Clinical Pathology|April 1, 1980
Legionnaires' disease. Postmortem pathologic findings of 20 casesF J Hernandez, B D Kirby, T M Stanley, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1982
Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organismsP H Edelstein, K A Pasiecznik, V K Yasui, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1982
Susceptibility of Legionella sp. and nosocomial respiratory tract isolates of Enterobacteriaceae to Sch 29482 and other beta-lactam agentsR D Meyer, K A Pasiecznik, V K Yasui, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia modelP H Edelstein, M A Edelstein, F Higa, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumoniaP H Edelstein, T Shinzato, E Doyle, et al.
Clinical and Diagnostic Laboratory Immunology|May 1, 1996
Utilization of tests for Lyme disease antibody at a university hospitalI Nachamkin, D L Riddle, M Feldman, et al.
Journal of Clinical Microbiology|December 1, 1981
Comparison of liquid growth media for Legionella pneumophilaA Saito, R D Rolfe, P H Edelstein, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumoniaP H Edelstein, M A Edelstein, J Weidenfeld, et al.
Journal of Clinical Microbiology|November 1, 1987
Legionella micdadei and Legionella dumoffii monoclonal antibodies for laboratory diagnosis of Legionella infectionsE Cercenado, P H Edelstein, L H Gosting, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumoniaP H Edelstein, M A Edelstein, K H Lehr, et al.
American Journal of Clinical Pathology|April 1, 1980
Legionnaires' disease. Postmortem pathologic findings of 20 casesF J Hernandez, B D Kirby, T M Stanley, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1982
Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organismsP H Edelstein, K A Pasiecznik, V K Yasui, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1982
Susceptibility of Legionella sp. and nosocomial respiratory tract isolates of Enterobacteriaceae to Sch 29482 and other beta-lactam agentsR D Meyer, K A Pasiecznik, V K Yasui, et al.
Pageof 12